| Gerri Kukucka, NP | |
|
5224 Sunset Blvd, Lexington, SC 29072-9259 | |
| (803) 796-4251 | |
| (803) 796-4449 |
| Full Name | Gerri Kukucka |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 4 Years |
| Location | 5224 Sunset Blvd, Lexington, South Carolina |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1740888262 | NPI | - | NPPES |
| NP8155 | Medicaid | SC |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | 24208 (South Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Kershawhealth | Camden, SC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Doctors Care, Pa | 6204731300 | 187 |
| Musc Community Physicians | 6507260668 | 698 |
News Archive
Wellington Foods, Inc., a leading nutritional supplement manufacturer, has announced the expansion of its production operation to its new headquarters in Corona, California. Moving to the larger state-of-the-art manufacturing facility, Wellington Foods has made a significant commitment to the long-term growth of the company and to the natural products industry.
The strategies used by the tobacco industry to counteract research linking tobacco smoke to cancer-causing mutations in a gene called p53 are detailed in a study published in The Lancet.
Archer Biosciences, Inc. announced that the trial of its novel, proprietary drug TPI-287 (an abeotaxane) for the treatment of metastatic melanoma has initiated a third drug-escalation cohort. The primary objective of this study is to determine the safety, tolerability and maximum tolerated dose (MTD) of TPI-287 in combination with temozolomide (TMZ) in adult patients with metastatic melanoma.
Vertex Pharmaceuticals Incorporated today announced positive results from a 24-week analysis of the ongoing Phase 3 ENVISION study of VX-770, an oral medicine in development that targets the defective protein that causes cystic fibrosis.
› Verified 6 days ago
| Entity Name | Doctors Care, Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366499048 PECOS PAC ID: 6204731300 Enrollment ID: O20040112000069 |
News Archive
Wellington Foods, Inc., a leading nutritional supplement manufacturer, has announced the expansion of its production operation to its new headquarters in Corona, California. Moving to the larger state-of-the-art manufacturing facility, Wellington Foods has made a significant commitment to the long-term growth of the company and to the natural products industry.
The strategies used by the tobacco industry to counteract research linking tobacco smoke to cancer-causing mutations in a gene called p53 are detailed in a study published in The Lancet.
Archer Biosciences, Inc. announced that the trial of its novel, proprietary drug TPI-287 (an abeotaxane) for the treatment of metastatic melanoma has initiated a third drug-escalation cohort. The primary objective of this study is to determine the safety, tolerability and maximum tolerated dose (MTD) of TPI-287 in combination with temozolomide (TMZ) in adult patients with metastatic melanoma.
Vertex Pharmaceuticals Incorporated today announced positive results from a 24-week analysis of the ongoing Phase 3 ENVISION study of VX-770, an oral medicine in development that targets the defective protein that causes cystic fibrosis.
› Verified 6 days ago
| Entity Name | App Of South Carolina Ed Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457878084 PECOS PAC ID: 3577821107 Enrollment ID: O20180103000650 |
News Archive
Wellington Foods, Inc., a leading nutritional supplement manufacturer, has announced the expansion of its production operation to its new headquarters in Corona, California. Moving to the larger state-of-the-art manufacturing facility, Wellington Foods has made a significant commitment to the long-term growth of the company and to the natural products industry.
The strategies used by the tobacco industry to counteract research linking tobacco smoke to cancer-causing mutations in a gene called p53 are detailed in a study published in The Lancet.
Archer Biosciences, Inc. announced that the trial of its novel, proprietary drug TPI-287 (an abeotaxane) for the treatment of metastatic melanoma has initiated a third drug-escalation cohort. The primary objective of this study is to determine the safety, tolerability and maximum tolerated dose (MTD) of TPI-287 in combination with temozolomide (TMZ) in adult patients with metastatic melanoma.
Vertex Pharmaceuticals Incorporated today announced positive results from a 24-week analysis of the ongoing Phase 3 ENVISION study of VX-770, an oral medicine in development that targets the defective protein that causes cystic fibrosis.
› Verified 6 days ago
| Entity Name | Grace Physicians Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700484821 PECOS PAC ID: 8628481090 Enrollment ID: O20201231000736 |
News Archive
Wellington Foods, Inc., a leading nutritional supplement manufacturer, has announced the expansion of its production operation to its new headquarters in Corona, California. Moving to the larger state-of-the-art manufacturing facility, Wellington Foods has made a significant commitment to the long-term growth of the company and to the natural products industry.
The strategies used by the tobacco industry to counteract research linking tobacco smoke to cancer-causing mutations in a gene called p53 are detailed in a study published in The Lancet.
Archer Biosciences, Inc. announced that the trial of its novel, proprietary drug TPI-287 (an abeotaxane) for the treatment of metastatic melanoma has initiated a third drug-escalation cohort. The primary objective of this study is to determine the safety, tolerability and maximum tolerated dose (MTD) of TPI-287 in combination with temozolomide (TMZ) in adult patients with metastatic melanoma.
Vertex Pharmaceuticals Incorporated today announced positive results from a 24-week analysis of the ongoing Phase 3 ENVISION study of VX-770, an oral medicine in development that targets the defective protein that causes cystic fibrosis.
› Verified 6 days ago
| Entity Name | Musc Community Physicians |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1841878006 PECOS PAC ID: 6507260668 Enrollment ID: O20210811002388 |
News Archive
Wellington Foods, Inc., a leading nutritional supplement manufacturer, has announced the expansion of its production operation to its new headquarters in Corona, California. Moving to the larger state-of-the-art manufacturing facility, Wellington Foods has made a significant commitment to the long-term growth of the company and to the natural products industry.
The strategies used by the tobacco industry to counteract research linking tobacco smoke to cancer-causing mutations in a gene called p53 are detailed in a study published in The Lancet.
Archer Biosciences, Inc. announced that the trial of its novel, proprietary drug TPI-287 (an abeotaxane) for the treatment of metastatic melanoma has initiated a third drug-escalation cohort. The primary objective of this study is to determine the safety, tolerability and maximum tolerated dose (MTD) of TPI-287 in combination with temozolomide (TMZ) in adult patients with metastatic melanoma.
Vertex Pharmaceuticals Incorporated today announced positive results from a 24-week analysis of the ongoing Phase 3 ENVISION study of VX-770, an oral medicine in development that targets the defective protein that causes cystic fibrosis.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Gerri Kukucka, NP 1818 Henderson St, Columbia, SC 29201-2619 Ph: (803) 758-2600 | Gerri Kukucka, NP 5224 Sunset Blvd, Lexington, SC 29072-9259 Ph: (803) 796-4251 |
News Archive
Wellington Foods, Inc., a leading nutritional supplement manufacturer, has announced the expansion of its production operation to its new headquarters in Corona, California. Moving to the larger state-of-the-art manufacturing facility, Wellington Foods has made a significant commitment to the long-term growth of the company and to the natural products industry.
The strategies used by the tobacco industry to counteract research linking tobacco smoke to cancer-causing mutations in a gene called p53 are detailed in a study published in The Lancet.
Archer Biosciences, Inc. announced that the trial of its novel, proprietary drug TPI-287 (an abeotaxane) for the treatment of metastatic melanoma has initiated a third drug-escalation cohort. The primary objective of this study is to determine the safety, tolerability and maximum tolerated dose (MTD) of TPI-287 in combination with temozolomide (TMZ) in adult patients with metastatic melanoma.
Vertex Pharmaceuticals Incorporated today announced positive results from a 24-week analysis of the ongoing Phase 3 ENVISION study of VX-770, an oral medicine in development that targets the defective protein that causes cystic fibrosis.
› Verified 6 days ago
Victoria Fenters, FNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1316 N Lake Dr, Lexington, SC 29072 Phone: 803-358-1191 | |
Dr. Brooke Patterson, DNP, FNP-C Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 815 Old Cherokee Rd, Lexington, SC 29072 Phone: 803-359-5181 | |
Mrs. Carolyn Birchmore, FNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1316 N Lake Dr, Lexington, SC 29072 Phone: 803-358-1191 Fax: 803-358-1180 | |
Amy Loper, APRN Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 811 W Main St Ste 207, Lexington, SC 29072 Phone: 803-358-6420 | |
Mrs. Willetta Rozena Jacobs, ARNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1847 S Lake Dr, Lexington, SC 29073 Phone: 803-356-8998 | |
Donna Marie Bridger, FNP-BC Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 2480 Two Notch Rd, Lexington, SC 29072 Phone: 803-951-5871 Fax: 803-951-5882 | |
Emilee Rikard Campbell, FNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 811 W Main St Ste 201&209, Lexington, SC 29072 Phone: 803-785-4777 Fax: 803-358-6240 |